Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best ...

Leukaemia & Lymphoma NI (LLNI) marked its 60th anniversary in style with a Black Tie and Diamonds Gala Ball, celebrating six ...

Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.

Chair of Tampa Light the Night, Laura Sherman, joins Gayle Guyardo, the host of the global health and wellness show, Bloom, ...

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

The Leukemia and Lymphoma Society is once again hosting Light The Night to bring light to the darkness of cancer. Last year, ...

a feature that represents an important hallmark of cancer. 16 We observed two peaks of CAR T-cell expansion. The first peak was clinically expected and eradicated the B-cell lymphoma, whereas the ...

The short but much-loved life of a French bulldog named George leaves a legacy of learning for those who care for animals and ...

An event aimed at spreading light and hope for patients and families dealing with the impacts of blood cancer returns Thursday.The Leukemia & Lymphoma Society's "Light the Night" event will return ...

Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...